International longitudinal registry of patients with atrial fibrillation and treated with rivaroxaban: RIVaroxaban Evaluation in Real life setting (RIVER)

Abstract Background Real-world data on non-vitamin K oral anticoagulants (NOACs) are essential in determining whether evidence from randomised controlled clinical trials translate into meaningful clinical benefits for patients in everyday practice. RIVER (RIVaroxaban Evaluation in Real life setting)...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Jan Beyer-Westendorf, A. John Camm, Keith A. A. Fox, Jean-Yves Le Heuzey, Sylvia Haas, Alexander G. G. Turpie, Saverio Virdone, Ajay K. Kakkar, for the RIVER Registry Investigators
Format: Artigo
Idioma:Inglês
Publicat: BMC 2019-04-01
Col·lecció:Thrombosis Journal
Matèries:
Anticoagulant
Antithrombotic
Atrial fibrillation
Outcomes
Registry
Rivaroxaban
Accés en línia:http://link.springer.com/article/10.1186/s12959-019-0195-7
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars